Skip to main
CVRX

CVRx (CVRX) Stock Forecast & Price Target

CVRx (CVRX) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 50%
Buy 33%
Hold 0%
Sell 17%
Strong Sell 0%

Bulls say

CVRx Inc. demonstrated growth in its operational capabilities, with a total of 240 active implanting centers at the end of the quarter, reflecting an increase of 13 centers sequentially. The company's investments in expanding its infrastructure are underscored by a year-over-year rise of approximately 11% in selling, general, and administrative expenses, contributing to total operating expenses of $25.8 million, which increased by around 8% year-over-year. This expansion in implanting centers and strategic spending indicates a positive trajectory for the company as it seeks to enhance its market presence in the cardiovascular device sector.

Bears say

CVRx has revised its FY25 revenue guidance downward, adjusting the top end to a range of $55.0 - $57.0 million, reflecting a modest year-over-year growth of approximately 7-11%, which raises concerns about overall growth momentum. Furthermore, the company's gross margin for 2Q25 remained stagnant at 84%, suggesting ongoing challenges in improving profitability. Lastly, revenue estimates for 2026 have also been reduced to $67.6 million from a prior estimate of $74.1 million, indicating a potential slowdown in US market performance and overall financial prospects.

CVRx (CVRX) has been analyzed by 6 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 17% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CVRx and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CVRx (CVRX) Forecast

Analysts have given CVRx (CVRX) a Buy based on their latest research and market trends.

According to 6 analysts, CVRx (CVRX) has a Buy consensus rating as of Dec 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $13.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $13.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CVRx (CVRX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.